125 related articles for article (PubMed ID: 24183234)
41. Bone marrow angiogenesis in systemic mast cell disease.
Baek JY; Li CY; Pardanani A; Butterfield JH; Tefferi A
J Hematother Stem Cell Res; 2002 Feb; 11(1):139-46. PubMed ID: 11847010
[TBL] [Abstract][Full Text] [Related]
42. Mast cell density is associated with angiogenesis and poor prognosis in pulmonary adenocarcinoma.
Takanami I; Takeuchi K; Naruke M
Cancer; 2000 Jun; 88(12):2686-92. PubMed ID: 10870050
[TBL] [Abstract][Full Text] [Related]
43. Diffuse MRI marrow pattern correlates with increased angiogenesis, advanced disease features and poor prognosis in newly diagnosed myeloma treated with novel agents.
Moulopoulos LA; Dimopoulos MA; Christoulas D; Kastritis E; Anagnostou D; Koureas A; Roussou M; Gavriatopoulou M; Migkou M; Iakovaki M; Gkotzamanidou M; Tasidou A; Terpos E
Leukemia; 2010 Jun; 24(6):1206-12. PubMed ID: 20428203
[No Abstract] [Full Text] [Related]
44. Immunohistochemical evaluation of mast cells and angiogenesis in oral squamous cell carcinoma.
Sharma B; Sriram G; Saraswathi TR; Sivapathasundharam B
Indian J Dent Res; 2010; 21(2):260-5. PubMed ID: 20657098
[TBL] [Abstract][Full Text] [Related]
45. Angiogenesis in multiple myeloma.
Vacca A; Ria R; Reale A; Ribatti D
Chem Immunol Allergy; 2014; 99():180-96. PubMed ID: 24217610
[TBL] [Abstract][Full Text] [Related]
46. Bone marrow mast cell immunophenotyping in adults with mast cell disease: a prospective study of 33 patients.
Pardanani A; Kimlinger T; Reeder T; Li CY; Tefferi A
Leuk Res; 2004 Aug; 28(8):777-83. PubMed ID: 15203275
[TBL] [Abstract][Full Text] [Related]
47. The relationship of mast cells and angiogenesis with prognosis in renal cell carcinoma.
Guldur ME; Kocarslan S; Ozardali HI; Ciftci H; Dincoglu D; Gumus K
J Pak Med Assoc; 2014 Mar; 64(3):300-3. PubMed ID: 24864604
[TBL] [Abstract][Full Text] [Related]
48. [Analysis of the international staging system of multiple myeloma and its comparison with the DS and IFM staging system in 122 Chinese patients].
Deng SH; Xu Y; Mai YJ; Wang YF; Zhao YZ; Zou DH; Qiu LG
Zhonghua Xue Ye Xue Za Zhi; 2008 Apr; 29(4):217-21. PubMed ID: 18843972
[TBL] [Abstract][Full Text] [Related]
49. Stage III multiple myeloma: clinical and prognostic value of spinal bone marrow MR imaging.
Lecouvet FE; Vande Berg BC; Michaux L; Malghem J; Maldague BE; Jamart J; Ferrant A; Michaux JL
Radiology; 1998 Dec; 209(3):653-60. PubMed ID: 9844655
[TBL] [Abstract][Full Text] [Related]
50. Prognostic significance of microvessel density and mast cell density for the survival of Thai patients with primary colorectal cancer.
Yodavudh S; Tangjitgamol S; Puangsa-art S
J Med Assoc Thai; 2008 May; 91(5):723-32. PubMed ID: 18672639
[TBL] [Abstract][Full Text] [Related]
51. [Prognostic value of the ratio of bone marrow plasma cells in multiple myeloma].
Pasqualetti P; Colantonio D; Casale R
Minerva Med; 1990 Mar; 81(3):129-33. PubMed ID: 2320280
[TBL] [Abstract][Full Text] [Related]
52. Prognostic significance of vascular endothelial growth factor immunoexpression in the context of adverse standard prognostic factors in multiple myeloma.
Ribas C; Colleoni GW; Silva MR; Carregoza MJ; Bordin JO
Eur J Haematol; 2004 Nov; 73(5):311-7. PubMed ID: 15458509
[TBL] [Abstract][Full Text] [Related]
53. [Abnormally lower expression of cmtm5 gene in bone marrow cells from patients with multiple myeloma].
Niu JH; Bao L; Zhang Y; Li JL; Li LD; Xie M; Qin YZ; Lai YY; Jiang Q; Shi HL; Liu YR; Jiang B; Chen SS; Huang XJ; Ruan GR
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Apr; 18(2):363-7. PubMed ID: 20416169
[TBL] [Abstract][Full Text] [Related]
54. Tryptase-positive mast cells accompany lymphocytic as well as lymphoplasmacytic lymphoma infiltrates in bone marrow trephine biopsies.
Wilkins BS; Buchan SL; Webster J; Jones DB
Histopathology; 2001 Aug; 39(2):150-5. PubMed ID: 11493331
[TBL] [Abstract][Full Text] [Related]
55. [Link between osteoclastogenesis, angiogenesis and myeloma expansion].
Abe M
Clin Calcium; 2008 Apr; 18(4):473-9. PubMed ID: 18379029
[TBL] [Abstract][Full Text] [Related]
56. Serum syndecan-1, basic fibroblast growth factor and osteoprotegerin in myeloma patients at diagnosis and during the course of the disease.
Kyrtsonis MC; Vassilakopoulos TP; Siakantaris MP; Kokoris SI; Gribabis DA; Dimopoulou MN; Angelopoulou MK; Pangalis GA
Eur J Haematol; 2004 Apr; 72(4):252-8. PubMed ID: 15089762
[TBL] [Abstract][Full Text] [Related]
57. The relationship of tryptase- and chymase-positive mast cells to angiogenesis in stage I non-small cell lung cancer.
Ibaraki T; Muramatsu M; Takai S; Jin D; Maruyama H; Orino T; Katsumata T; Miyazaki M
Eur J Cardiothorac Surg; 2005 Oct; 28(4):617-21. PubMed ID: 16125954
[TBL] [Abstract][Full Text] [Related]
58. Four proteins governing overangiogenic endothelial cell phenotype in patients with multiple myeloma are plausible therapeutic targets.
Berardi S; Caivano A; Ria R; Nico B; Savino R; Terracciano R; De Tullio G; Ferrucci A; De Luisi A; Moschetta M; Mangialardi G; Catacchio I; Basile A; Guarini A; Zito A; Ditonno P; Musto P; Dammacco F; Ribatti D; Vacca A
Oncogene; 2012 May; 31(18):2258-69. PubMed ID: 21963844
[TBL] [Abstract][Full Text] [Related]
59. Angiogenesis in the bone marrow of patients with breast cancer.
Chavez-Macgregor M; Aviles-Salas A; Green D; Fuentes-Alburo A; Gómez-Ruiz C; Aguayo A
Clin Cancer Res; 2005 Aug; 11(15):5396-400. PubMed ID: 16061853
[TBL] [Abstract][Full Text] [Related]
60. Interleukin-10 Induces Both Plasma Cell Proliferation and Angiogenesis in Multiple Myeloma.
Alexandrakis MG; Goulidaki N; Pappa CA; Boula A; Psarakis F; Neonakis I; Tsirakis G
Pathol Oncol Res; 2015 Sep; 21(4):929-34. PubMed ID: 25743259
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
